131
Views
15
CrossRef citations to date
0
Altmetric
Review

Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness

, &
Pages 493-503 | Published online: 02 Mar 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jacqueline R. Glenn, Ann E. White, Andrew Johnson, Susan C. Fox, Miles W.H. Behan, Gerry Dolan & Stanley Heptinstall. (2005) Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood. Platelets 16:3-4, pages 159-170.
Read now

Articles from other publishers (14)

Emanuela Marcantoni, Michael S. Garshick, Tamar Schwartz, Nicole Ratnapala, Matthew Cambria, Rebecca Dann, Meagan O’Brien, Adriana Heguy & Jeffrey S. Berger. (2022) Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV. JACC: Basic to Translational Science 7:11, pages 1086-1097.
Crossref
Mei-Tzu Wang, Cheng Chung Hung, Kun-Chang Lin, Guang-Yuan Mar, Shu-Hung Kuo, Cheng-Hung Chiang, Chin-Chang Cheng, Feng-You Kuo, Hsing-Li Liang & Wei-Chun Huang. (2020) Comparison of effects of triple antithrombotic therapy and dual antiplatelet therapy on long-term outcomes of acute myocardial infarction. Heart and Vessels 36:3, pages 345-358.
Crossref
Ya-Ou Liu, Zi-Ning Wang, Chao-Yang Chen, Xian-Han Zhuang, Chang-Geng Ruan, Ying Zhou & Yi-Min Cui. (2020) Antiplatelet Effect of a Pulaimab [Anti-GPIIb/IIIa F(ab)2 Injection] Evaluated by a Population Pharmacokinetic-pharmacodynamic Model. Current Drug Metabolism 20:13, pages 1060-1072.
Crossref
Rami M. Abazid, Ahmad Almeman, Akram F Eldesoky, Habiba S. Alenzi, Nora A. Altorbak, Sarah A. Altorbak, Bashayer Almotyri & Osama A. Smettei. (2021) Predictive and prognostic value of 256-slice computed tomography angiography in patients with suspected coronary artery diseases. Avicenna Journal of Medicine 9:01, pages 23-27.
Crossref
Elvira D’Andrea, Iveta Nagyova & Paolo Villari. 2015. A Systematic Review of Key Issues in Public Health. A Systematic Review of Key Issues in Public Health 33 64 .
Danny Liew, Richard De Abreu Lourenço, Michael Adena, Lesley Chim & Philip Aylward. (2013) Cost-Effectiveness of 12-Month Treatment With Ticagrelor Compared With Clopidogrel in the Management of Acute Coronary Syndromes. Clinical Therapeutics 35:8, pages 1110-1117.e9.
Crossref
Saurabh Aggarwal, Rohit Seth Loomba & Rohit Arora. (2012) Preventive aspects in peripheral artery disease. Therapeutic Advances in Cardiovascular Disease 6:2, pages 53-70.
Crossref
Yona Bismuth-Evenzal, Netta Roz, David Gurwitz & Moshe Rehavi. (2010) N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor. Biochemical Pharmacology 80:10, pages 1546-1552.
Crossref
Graeme J Hankey. (2010) Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs?. Current Opinion in Neurology 23:1, pages 65-72.
Crossref
B-A You, H-Q Gao, G-S Li, X-Y Huo & L-Y Qie. (2009) Vascular Compliance is Reduced in Geriatric People with Angiographic Coronary Atherosclerosis. Journal of International Medical Research 37:5, pages 1443-1449.
Crossref
Jamila K Adam & Wafaa N S Rmaih. (2008) A Double-blind Placebo-controlled Investigation of the Psychomotor Profile of Clopidogrel in Healthy Volunteers. Journal of Cardiovascular Pharmacology 52:6, pages 507-509.
Crossref
Olga Bruno, Chiara Brullo, Silvia Schenone, Francesco Bondavalli, Angelo Ranise, Massimiliano Tognolini, Mariannina Impicciatore, Vigilio Ballabeni & Elisabetta Barocelli. (2006) Synthesis, antiplatelet and antithrombotic activities of new 2-substituted benzopyrano[4,3-d]pyrimidin-4-cycloamines and 4-amino/cycloamino-benzopyrano[4,3-d]pyrimidin-5-ones. Bioorganic & Medicinal Chemistry 14:1, pages 121-130.
Crossref
Carme Piñol. (2013) Análisis de coste-efectividad del ácido acetilsalicílico frente al clopidogrel en prevención secundaria tras infarto agudo de miocardio. PharmacoEconomics Spanish Research Articles 2:3, pages 101-110.
Crossref
. (2004) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 13:8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.